Wim Weyenberg, PharmD, MS, RPh, BBA, PhD
Married with 3 sons
Dr. Wim Weyenberg has gained over 16 years’ experience within the pharmaceutical industry on multiple Therapeutic Areas and with variety roles and responsibilities, including Medical Affairs, Market Access, Patient Liaison Programs, Life Cycle Management, Project Management and Pharmaceutical Development.
Wim is Senior Director in the Specialty Life Cycle Management Division at Teva Pharmaceuticals and responsible for the Life Cycle Management and Compound Strategy Programs where he leads the cross-functional Specialty Life Cycle teams working on CNS, Women’s Health and Oncology and supports, plans and drives the compound developmental innovations. He started his career as Project Team Lead at Johnson & Johnson, working in the R&D division. Progressing to a career in management consulting and working at IMS Health, he advised as Senior Consultant international clients across the Pharmaceutical and Healthcare industries, with a focus on Product and Portfolio Strategy and Development. In 2010, he joined Shire Pharmaceutical where he led the Regional Medical Affairs and Market Access activities in Belgium, the Netherlands and Switzerland, for the Orphan Drugs in the area of rare diseases, including Fabry disease, Hunter Syndrome and Gaucher disease.
He graduated with a Pharm. D. and obtained his Ph.D. in Pharmaceutics at the University of Antwerp in Belgium. He also completed postgraduate studies in Business Administration.
Global DirectorAmsterdam, Wilrijk, Basel
Since January 2013
Global Director, Life Cycle Management, TEVA, Global/EU HQ in Amsterdam (2013-present)
Lead, plan and manage the proposition of modules and implementation of global improvement project strategies (US, EU and Growth Markets) to maximize the life cycles of 14 specialty products (CNS/Multiple Sclerosis, Respiratory, Oncology, Women’s Health) along with project resolutions with internal and external partners. Cultivation of business partnerships to support Life Cycle and Project Management ideas and activities with different internal stakeholders, including R&D, Intellectual Property, Business Development, Commercial, Patient Value, Market Access, Regulatory Affairs, Market Intelligence, Governmental Affairs and Medical Affairs.
Regional Medical Lead - Medical Affairs Benelux-Swi Brussels, BelgiumDecember 2010 --- March 2013
Senior Consultant - Product & Portfolio Strategy Brussels / LondonFebruary 2007 --- December 2010
Project Lead Beerse, BelgiumSeptember 2005 --- February 2007
Assistant Galenics Antwerp, BelgiumSeptember 2000 --- September 2005
Analytical thinkingInterest in knowledgePerspectiveStrategic thinkingWillingness to compromiseResult OrientedSelf-disciplineResponsibilityInnovative thinkingFlexibilityCuriosityCreative thinkingCoordinationCommunicativeCollaborationCharmAttention to detailTrust
Diabetes Biochemistry R&D NegotiationPresentationsPricingProblem SolvingProblem-solving methods and troubleshootingProduct developmentProduct launchProduct managementProduct MarketingProgram ManagementProject PlanningProject ManagementProject Portfolio ManagementRegulatory StrategiesRespiratoryscienceStrategic PlanningStrategyTeam LeadershipTeam ManagementTeamworkTechnology DevelopmentTechnological InnovationUrologyVaccinesWomens HealthpharmacologyPharmacistsPharmaceuticalsPharmaceuticsOphthalmologyoncologyNew Business DevelopmentNeuroscienceNeurologyNanotechnologyMS ProjectMicrosoft WordMicrosoft ProjectMedical budget managementMedical affairsLife SciencesLeadershipKOL managementImmunologyEntrepreneurshipEnglishDue DiligenceDrug DevelopmentDrug AccountabilityDiabetesCompetitive AnalysisCNSBusiness DevelopmentBusiness IntelligenceBusiness ProcessBudget Management
Skills and Expertise
Analytical skillsDevelop business planEvaluate licensing opportunitiesForecasting of drug productIdentify market opportunitiesInteract with pharmacistsInteract with physiciansLead teamslifesciencePatient liaisonproject managementPromotional materialsStudy execution plan
PhD in Pharmaceutics from University of Antwerp in 2005
Master Industry Pharmacy in Pharmaceutical Sciences from University of Antwerp in 2001
PharmD in Pharmacy from University of Antwerp in 2000
Training and Certification
PhD in 2005 Certification